Adherence and patients’ experiences with oral anticancer agents.
Completed
- Conditions
- cancer
- Registration Number
- NL-OMON21194
- Lead Sponsor
- VU University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Patients with cancer of 18 years and older who have filled at least one prescription for an oral anticancer agent in the past period of three months.
Exclusion Criteria
1. Patients younger than 18 years;
2. Treatment in the (neo)adjuvant setting;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence rate.
- Secondary Outcome Measures
Name Time Method 1. Nature and grade of side effects as perceived by the patient;<br /><br>2. Attitude towards disease;<br /><br>3. Beliefs and attitude towards medication;<br /><br>4. Information received about the medication;<br /><br>5. Quality of life;<br /><br>6. Adherence by means of Medication Adherence Rating Scale (MARS);<br /><br>7. Dose adjustment;<br /><br>8. Discontinuation;<br /><br>9. Age;<br /><br>10. Gender;<br /><br>11. Partner status;<br /><br>12. Socio-economic status;<br /><br>13. Disease stage.